Catalyst Biosciences, Inc. Profile Avatar - Palmy Investing

Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecul…

Biotechnology
US, South San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CBIO's Analysis
CIK: 1124105 CUSIP: 14888D208 ISIN: US4037831033 LEI: - UEI: -
Secondary Listings
CBIO has no secondary listings inside our databases.